US 11059880
Redirected cells with MHC chimeric receptors and methods of use in immunotherapy
granted A61KA61K2239/31A61K40/11
Quick answer
US patent 11059880 (Redirected cells with MHC chimeric receptors and methods of use in immunotherapy) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2239/31, A61K40/11, A61K40/32, A61K40/48